Tracey K J, Cerami A
Division of Neurosurgery, New York Hospital-Cornell University Medical Center, New York 10021.
Ann N Y Acad Sci. 1989;569:211-8. doi: 10.1111/j.1749-6632.1989.tb27371.x.
Cachexia and septic shock, syndromes associated with chronic and acute infection, respectively, are mediated by endogenous factors. The search for humoral mediators of cachexia led to the isolation of the cytokine known as cachectin/TNF. A biologic role for cachectin/TNF in cachexia has been identified: it induces a catabolic state in adipose and skeletal muscle cells in vitro, and animals persistently exposed to it in vivo become cachectic. Cachectin/TNF was also discovered to be a primary, essential mediator of septic shock. The acute administration of the recombinant protein causes shock, tissue injury, and derangements of metabolic homeostasis that mimic endotoxemia and septic shock syndrome. Anti-cachectin antibodies protect against the lethal effects of septic shock and cachexia, suggesting that this mediator has a central role as a trigger to the inflammatory and deleterious host responses to infection. Future investigations will undoubtedly be directed towards the effects of inhibiting cachectin/TNF in the treatment of the complications of infectious disease.
恶病质和脓毒症休克分别是与慢性感染和急性感染相关的综合征,由内源性因素介导。对恶病质体液介质的研究导致了被称为恶病质素/肿瘤坏死因子(cachectin/TNF)的细胞因子的分离。恶病质素/肿瘤坏死因子在恶病质中的生物学作用已得到确认:它在体外可诱导脂肪和骨骼肌细胞进入分解代谢状态,在体内持续接触该因子的动物会出现恶病质。恶病质素/肿瘤坏死因子还被发现是脓毒症休克的主要必需介质。重组蛋白的急性给药会引发休克、组织损伤以及代谢稳态紊乱,这些表现类似于内毒素血症和脓毒症休克综合征。抗恶病质素抗体可预防脓毒症休克和恶病质的致死效应,这表明该介质作为引发宿主对感染的炎症和有害反应的触发因素起着核心作用。未来的研究无疑将朝着抑制恶病质素/肿瘤坏死因子在治疗传染病并发症方面的效果展开。